Market Dynamics and Pricing Positioning for Specific Synthetic Products and Small Molecules Active Pharmaceutical Ingredients (APIs)

CHALLENGE

A tier 1 private equity firm engaged a global strategy consulting firm to conduct a commercial due diligence (CDD) project focused on market dynamics and pricing positioning for specific synthetic products and small molecule Active Pharmaceutical Ingredients (APIs). The objective was to provide a comprehensive analysis of market trends, competitive pricing strategies, and key factors influencing the API sector.

BTHT APPROACH

After a detailed briefing with the consulting firm and a clear understanding of the project’s scope, the BTHT team swiftly identified and engaged top industry experts. They reached out to former executives from Contract Development and Manufacturing Organizations (CDMOs) and Business Unit (BU) Managers with extensive experience in synthetic products and small molecules APIs. The team arranged and facilitated a series of high-level expert calls, ensuring each discussion was both insightful and seamlessly executed.

OUTCOME

The BTHT team successfully connected the client with seasoned former CDMO executives and BU Managers, providing rich insights into the market dynamics and pricing strategies for synthetic products and small molecules APIs. The expert calls delivered valuable information on current market trends, competitive positioning, and strategic pricing approaches. This in-depth analysis enabled the consulting firm to offer the private equity client a robust and actionable assessment, supporting strategic investment decisions and providing a clear understanding of the competitive landscape in the API sector.